Clinical Trials Browser

Phase 1 × Mouth Neoplasms × toripalimab × Clear all

NCT04473716 2023-11-22

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

Phase 1 Completed

Mouth Neoplasms